Comparison

Angiotensin II (3-8), human (TFA) European Partner

Item no. HY-P1515A-5mg
Manufacturer MedChem Express
Amount 5 mg
Quantity options 10 mMx1 mL 10 mg 25 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.90
Citations [1]Gardiner SM, et al. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol. 1993 Sep;110(1):159-62.
Theranostics. 2021 Jul 25;11(18):8624-8639.|Eur J Pharmacol. 2019 Mar 13;853:93-102.
Smiles O=C(O)C(F)(F)F.O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)[C@H](C(C)C)N
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Type
Peptides
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Angiotensin Receptor
Shipping Temperature
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Molecular Weight
888.93
Product Description
Angiotensin II (3-8), human (TFA) is a less effective agonist at the angiotensin AT1 receptor.
Manufacturer - Research Area
Cardiovascular Disease; Endocrinology
Solubility
H2O: 50 mg/mL (ultrasonic)
Manufacturer - Pathway
GPCR/G Protein
Isoform
AT1 Receptor
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close